Fierce Healthcare

AUGUST 9, 2021

New survey finds COVID-19 is taking a significant toll on physicians. agliadkovskaya. Mon, 08/09/2021 - 15:51.

143

143

Outsourcing Pharma

AUGUST 9, 2021

Nanomeâs virtual reality tech is being put to use by Oak Ridge National Laboratory and top pharma firms to study COVID-19 and explore drug candidates.

137

137

pharmaphorum

AUGUST 10, 2021

Researchers at Cambridge University in the UK are trialling an artificial intelligence system that they think could spot the signs of dementia after a single brain scan. The team – led by Prof Zoe Kourtzi of the university and Alan Turing Institute – told the BBC that the AI could make it possible to start treatment earlier to slow down progression of Alzheimer’s disease and other forms of dementia.

Hospitals 137

Hospitals 137

Pharma Marketing Network

AUGUST 11, 2021

Tune in with the Pharma Marketing Network for an insightful conversation with R.J. Lewis and Diane Bartoli, VP and General Manager of epocrates, as she shares her background with eCME, how COVID-19 has been driving it’s rapid growth, the other digital channels that have come into play, the term “snackable eCME” and how we can expect eCME to trend in a post-COVID sense.

97

97

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharma Times

AUGUST 13, 2021

First and only FDA-approved treatment for the neurological sleep disorder

FDA 52

FDA 52

Outsourcing Pharma

AUGUST 10, 2021

The US-based company continues its move away from smoking products with the purchase of drug developer OtiTopic, as part of its Beyond Nicotine initiative.

115

115

Pharma Marketing Network

AUGUST 13, 2021

Sunny drives the promotion of global brands for pharmaceutical, biotech and medical. device. She founded Xavier Creative House (XCH), a healthcare marketing agency that. builds BOLD and EVOCATIVE designs, pushing the edge of creativity. Sunny is the point person for positioning your brand into a “Powerhouse.” As, CEO, she leads Operations and Client Management utilizing a wealth of experience gained from her roles in communications, compliance, and sales in rapid-growth companies.

Communication 52

Communication 52

Pharma Times

AUGUST 12, 2021

Cost-effectiveness watchdog initially rejected the drug in February

52

52

Outsourcing Pharma

AUGUST 9, 2021

A leader from Longboat by Advarra outlines what it really means for a study to be patient centric, and how to succeed in achieving patient-centric trials.

111

111

pharmaphorum

AUGUST 10, 2021

Oxford University and UK clinical artificial intelligence (AI) company Sensyne Health will partner on a project to find new drug targets for people with hard-to-treat asthma. It’s estimated that almost one in five people with asthma find it difficult to control symptoms using current therapies, while around 4% have particularly severe forms that puts them at risk of life-threatening attacks.

Hospitals 116

Hospitals 116

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PDS Blog

AUGUST 12, 2021

Every year it’s the same story – January 1st rolls around, and vitamins fly off the shelves as everyone vows to eat healthier, live better, and take care of themselves in the new year. But about halfway through those vitamin bottles, they are forgotten, to be guiltily looked upon whenever you need a cup or something from […]. The post Even Pharmacists Should Take Their Vitamins in 2021 appeared first on Pharmacy Development Services.

Independent Pharmacies 52

Independent Pharmacies 52

Pharma Times

AUGUST 11, 2021

Collaboration will drive medicines discovery in areas of unmet patient need

52

52

Outsourcing Pharma

AUGUST 10, 2021

The University of Illinois at Chicago has been given $6m from the US Department of Defense to develop a potential treatment for severe cases of COVID-19.

111

111

pharmaphorum

AUGUST 10, 2021

BioNTech has suggested that giving booster doses of its current Comirnaty (BNT162b2) COVID-19 vaccine may be a preferable strategy to modifying the Pfizer-partnered shot. The comments came on the German biotech’s second-quarter results call, during which BioNTech raised its forecasts for revenues it will book from sales of the vaccine to €15.9 billion (almost $19 billion), on the back of contracts to deliver 2.2 billion doses this year with more than 1 billion already booked in for 2022.

Vaccines 116

Vaccines Immunization 116

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Lifewell Rx Pharmacy

AUGUST 10, 2021

It may be difficult to keep track of your medications, especially if you are taking several at a time. However, it is important to stay on track with your medications, as missing a dose may affect your treatment and put you at risk of side effects. As a community pharmacy in Kentucky , we would like to help our customers manage their medications better to ensure their health and well-being.

Independent Pharmacies 52

Independent Pharmacies Community Pharmacies Dosage 52

Pharma Times

AUGUST 10, 2021

Approval represents a new indication for GW's cannabidiol in the UK

52

52

Outsourcing Pharma

AUGUST 11, 2021

The US Food and Drug Administration has kept its staff busy with approvals, authorizations, and warnings related to various coronavirus-centered products.

FDA 98

FDA 98

pharmaphorum

AUGUST 12, 2021

The UK government has started ordering COVID-19 vaccines for a 2022 booster campaign, including a 32 million-dose order for the Pfizer/BioNTech shot, even before third doses for 2021 have been given the go-ahead. A report in The Times claims that the government is paying £22 a dose – up from an earlier price of £18 – for the Pfizer/BioNTech vaccine as part of a £1 billion deal for additional supplies, which is needed because existing stocks will be depleted next year.

Vaccines 111

Vaccines Immunization 111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Med Ed 101

AUGUST 11, 2021

Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside of hospitals, (less than 48 hours from hospital admission). Patients will typically present with symptoms including fever, chills, chest pain, cough, sputum production, and dyspnea. Objective findings may include increased HR, respiratory rate >20 breaths/min, elevated WBC, crackles on auscultation, and evidence of consolidation (decreased breath […].

Hospitals 40

Hospitals 40

Pharma Times

AUGUST 13, 2021

Variants studied included Alpha, Beta, Gamma, Delta, Epsilon and Iota

Vaccines 52

Vaccines 52

Outsourcing Pharma

AUGUST 12, 2021

The World Health Organizationâs Solidarity PLUS trial will kick off in 52 countries, trialing three drugs to treat patients hospitalized with COVID-19.

Hospitals 98

Hospitals 98

pharmaphorum

AUGUST 12, 2021

With advertisers preparing to spend up to $15 billion on influencer marketing by 2022, pharmaceutical and biotech companies are increasingly (and carefully) engaging trusted health social influencers to connect more authentically with consumers. As pharma starts to leverage a multitude of high-engagement channels like influencer marketing, online communities and virtual health services, the industry finds itself in a unique position to reimagine traditional direct-to-consumer (DTC) efforts and p

Communication 111

Communication 111

Med Ed 101

AUGUST 8, 2021

Proton Pump Inhibitors (PPIs) are a well-known staple in the management of upper GI bleeds (UGIB). Recently, there was a question regarding the efficacy and appropriateness of PPI use in lower GI bleeds (LGIB). First, let’s evaluate some common characteristics used to differentiate between an UGIB and LGIB. Upper GI Bleed Hematemesis: vomiting both bright […].

40

40

Pharma Times

AUGUST 9, 2021

Trial compared Enhertu with T-DM1 in patients with HER2-positive breast cancer

52

52

Outsourcing Pharma

AUGUST 10, 2021

The pharma firm is working with five US colleges and universities onto create programming designed to boost recruitment of Black talent in the industry.

94

94

pharmaphorum

AUGUST 9, 2021

AstraZeneca’s Forxiga has become the first SGLT2 inhibitor to be approved in Europe for use in people with chronic kidney disease, extending its lead over rival drugs in the class. The European Commission has cleared Forxiga (dapagliflozin) for CKD in adults with or without diabetes, and the drug becomes the first new drug treatment for these patients in more than two decades.

FDA 111

FDA 111

pharmaphorum

AUGUST 13, 2021

Israeli femtech start-up GinaLife is developing a platform of biomarker strategies supported by artificial intelligence and data science for the early detection of problems in women’s health. CEO and co-founder Inbal Zafir-Lavie tells pharmaphorum more. Six years ago, research scientist Inbal Zafir-Lavie tragically lost her 38-year-old sister Hava Zafir to colorectal cancer.

105

105

pharmaphorum

AUGUST 10, 2021

How could simplifying the administration of clinical trials help cancer diagnosis, care, and treatment levels to exceed pre-pandemic levels? Amanda Barrell reports from the ABPI Scotland cancer roundtable discussion. Work to get Scotland’s cancer services back to full strength following the pandemic has already begun, and the pharmaceutical industry has pledged to play its part.

Documentation 105

Documentation 105

pharmaphorum

AUGUST 9, 2021

Australian telecommunications giant Telstra has reached a deal to acquire MedicalDirector, a company specialising in software used by GPs to manage their practices. Telstra Health – the Australian group’s digital health arm – is paying A$350 million ($257 million) to buy MedicalDirector from investment company Affinity Equity Partners, which bought the company from former owner Healius for A$155 million in 2016.

Hospitals 105

Hospitals 105

pharmaphorum

AUGUST 12, 2021

Health insurer Excellus BlueCross BlueShield has said it will not cover treatment with Biogen and Eisai’s new Alzheimer’s disease drug Aduhelm because it has not been shown to be medically effective. The company – said to be the largest health insurer in New York – said in a statement that Aduhelm (aducanumab) remains an investigational drug, even though it was approved by the FDA in June for Alzheimer’s, according to a media report.

Insurance 98

Insurance Department of Veterans Affairs FDA 98

pharmaphorum

AUGUST 11, 2021

South Korea’s SK Bioscience has been given the all-clear to start a phase 3 trial of its COVID-19 vaccine GBP510 that will compare the shot directly with AstraZeneca’s Vaxzevria. It is the first COVID-19 vaccine developed in South Korea to reach the pivotal trial stage, and from the earliest stages of its development has been earmarked as a possible candidate for rollout at scale across developing countries via the COVAX programme.

Vaccines 98

Vaccines Immunization 98

pharmaphorum

AUGUST 9, 2021

People across the world, especially the population aged 65 years or older, are suffering from some form of a medical condition that results in tooth decay or loss. According to statistics released by the Centers for Disease Control and Prevention, around 70.1% of the population in North America was 65 years or more and was suffering from a periodontal disease as well that resulted in loss of teeth.

Hospitals 98

Hospitals 98

pharmaphorum

AUGUST 9, 2021

Sanofi has added another string to its Pompe disease therapy bow, after getting FDA approval for Nexviazyme, its latest therapy for the rare, inherited disorder. The US regulator has approved Nexviazyme (avalglucosidase alfa) for the treatment of patients aged one year of age and older with late-onset Pompe disease , which progressively attacks the heart and skeletal muscles.

FDA 98

FDA Labelling 98